<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Eaton N</submitter><funding>National Heart, Lung, and Blood Institute</funding><funding>NHLBI NIH HHS</funding><funding>American Society of Hematology</funding><pagination>959806</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9468709</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>12</volume><pubmed_abstract>&lt;i>Dnm2&lt;sup>fl/fl&lt;/sup> Pf4-Cre&lt;/i> (&lt;i>Dnm2&lt;sup>Plt-/-&lt;/sup>&lt;/i> ) mice lacking the endocytic GTPase dynamin 2 (DNM2) in platelets and megakaryocytes (MKs) develop hallmarks of myelofibrosis. At the cellular level, the tyrosine kinase JAK2 is constitutively active but decreased in expression in &lt;i>Dnm2&lt;sup>Plt-/-&lt;/sup>&lt;/i> platelets. Additionally, &lt;i>Dnm2&lt;sup>Plt-/-&lt;/sup>&lt;/i> platelets cannot endocytose the thrombopoietin (TPO) receptor Mpl, leading to elevated circulating TPO levels. Here, we assessed whether the hyperproliferative phenotype of &lt;i>Dnm2&lt;sup>Plt-/-&lt;/sup>&lt;/i> mice was due to JAK2 constitutive activation or to elevated circulating TPO levels. In unstimulated &lt;i>Dnm2&lt;sup>Plt-/-&lt;/sup>&lt;/i> platelets, STAT3 and, to a lower extent, STAT5 were phosphorylated, but their phosphoryla</pubmed_abstract><journal>Frontiers in oncology</journal><pubmed_title>Endocytosis of the thrombopoietin receptor Mpl regulates megakaryocyte and erythroid maturation in mice.</pubmed_title><pmcid>PMC9468709</pmcid><funding_grant_id>P01 HL046925</funding_grant_id><funding_grant_id>K12 HL141954</funding_grant_id><funding_grant_id>P01 HL151333</funding_grant_id><funding_grant_id>R01 HL126743</funding_grant_id><funding_grant_id>HL046925, HL089224, HL141954, HL151333, HL126743</funding_grant_id><funding_grant_id>R01 HL089224</funding_grant_id><pubmed_authors>Hoffmeister KM</pubmed_authors><pubmed_authors>Lee-Sundlov MM</pubmed_authors><pubmed_authors>Boyd EK</pubmed_authors><pubmed_authors>Falet H</pubmed_authors><pubmed_authors>Sola-Visner MC</pubmed_authors><pubmed_authors>Zheng S</pubmed_authors><pubmed_authors>Biswas R</pubmed_authors><pubmed_authors>Ramsey HE</pubmed_authors><pubmed_authors>Dlugi TA</pubmed_authors><pubmed_authors>Eaton N</pubmed_authors><pubmed_authors>Burns RT</pubmed_authors></additional><is_claimable>false</is_claimable><name>Endocytosis of the thrombopoietin receptor Mpl regulates megakaryocyte and erythroid maturation in mice.</name><description>&lt;i>Dnm2&lt;sup>fl/fl&lt;/sup> Pf4-Cre&lt;/i> (&lt;i>Dnm2&lt;sup>Plt-/-&lt;/sup>&lt;/i> ) mice lacking the endocytic GTPase dynamin 2 (DNM2) in platelets and megakaryocytes (MKs) develop hallmarks of myelofibrosis. At the cellular level, the tyrosine kinase JAK2 is constitutively active but decreased in expression in &lt;i>Dnm2&lt;sup>Plt-/-&lt;/sup>&lt;/i> platelets. Additionally, &lt;i>Dnm2&lt;sup>Plt-/-&lt;/sup>&lt;/i> platelets cannot endocytose the thrombopoietin (TPO) receptor Mpl, leading to elevated circulating TPO levels. Here, we assessed whether the hyperproliferative phenotype of &lt;i>Dnm2&lt;sup>Plt-/-&lt;/sup>&lt;/i> mice was due to JAK2 constitutive activation or to elevated circulating TPO levels. In unstimulated &lt;i>Dnm2&lt;sup>Plt-/-&lt;/sup>&lt;/i> platelets, STAT3 and, to a lower extent, STAT5 were phosphorylated, but their phosphoryla</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022</publication><modification>2026-04-08T11:56:08.074Z</modification><creation>2025-02-19T03:29:19.768Z</creation></dates><accession>S-EPMC9468709</accession><cross_references><pubmed>36110936</pubmed><doi>10.3389/fonc.2022.959806</doi></cross_references></HashMap>